Abstract
The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Current Topics in Medicinal Chemistry
Title: Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs
Volume: 11 Issue: 21
Author(s): Adoracion G. Quiroga
Affiliation:
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Abstract: The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Export Options
About this article
Cite this article as:
G. Quiroga Adoracion, Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs, Current Topics in Medicinal Chemistry 2011; 11 (21) . https://dx.doi.org/10.2174/156802611798040723
DOI https://dx.doi.org/10.2174/156802611798040723 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Validation and Development of N-glycan as Biomarker in Cancer Diagnosis
Current Pharmacogenomics and Personalized Medicine Targeting Focal Adhesion Kinase in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration
Current Drug Targets EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs
Current Gene Therapy Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse
Anti-Cancer Agents in Medicinal Chemistry FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research The Influence of Macrophages and the Tumor Microenvironment on Natural Killer Cells
Current Molecular Medicine The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Current Pharmaceutical Design Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Current Pharmaceutical Design Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Enhancing the Cytotoxic Activity of Novel Targeted Therapies – Is There a Role for a Combinatorial Approach?
Current Clinical Pharmacology Polysaccharide Colloids as Smart Vehicles in Cancer Therapy
Current Pharmaceutical Design Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging New Platinum and Ruthenium Complexes - the Latest Class of Potential Chemotherapeutic Drugs - a Review of Recent Developments in the Field
Mini-Reviews in Medicinal Chemistry The Interaction of NK Cells and Dendritic Cells in the Tumor Environment: How to Enforce NK Cell & DC Action Under Immunosuppressive Conditions?
Current Medicinal Chemistry Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities
Current Drug Metabolism ROS1 Kinase Inhibitors for Molecular-Targeted Therapies
Current Medicinal Chemistry